5 CV innovations bound to make an impact in 2020

Cleveland Clinic revealed its predictions for the top 10 medical innovations of 2020 on Oct. 23, naming five cardiovascular concepts in the process.

A CV innovation didn’t take the number-one slot for next year’s anticipated heavyweights—that was a recently FDA-approved dual-acting osteoporosis drug known as romosozumab—but half of Cleveland Clinic’s predictions had to do with cardiology. A panel of physicians and researchers led by Michael Roizen, MD, emeritus chief wellness officer at Cleveland Clinic, ranked the up-and-coming tech.

Click here to read the complete article.

Story excerpt provided by Cardiovascular Business.

Written by Anicka Slachta.

Originally published October 29, 2019.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: